Expanded Access Requests at the Medical College of Wisconsin
FDA regulations ordinarily require prior approval from FDA and an IRB for research use of an unapproved or "investigational" drug, biologic, or device. Exceptions to this rule apply in very limited cases, including life-threatening emergencies.
Expanded Access
Policies on Conventional Expanded Access Requests
Expanded Access Request Resources
Emergency Use
Policies on Emergency Use of Investigational Devices, Drugs and Biologics
Emergency Use Request Resources
Emergency Use HRPP Office Notification
Call (414) 955-8337 or (414) 955-4415 and email the MCW HRPP Office as soon as the decision to use an unapproved or investigational drug, device or biologic is made, prior to the treatment or procedure if at all possible.
HRPP office hours are Monday-Friday 8 a.m. - 5 p.m. If the use happens after office hours, call (414) 955-8439 and leave a message with call back number.
Consent Form Templates
Treatment Use Template (DOCX)
This template (Emergency/Treatment Use) is for treatment uses involving investigational drugs/devices/biologics for the treatment of patients not in a clinical trial.
Emergency Use ICF Template (DOCX)
This template (Emergency Use) is for treatment uses involving investigational drugs/devices/biologics for the treatment of patients not in a clinical trial. This template is to be used for the treatment of patients in a life-threatening situation where prior IRB review and approval is not feasible.
HUD Template (DOCX)
This template is for use of a Humanitarian Use Device. Please contact the IRB office prior to use of this template.
EFIC Template (DOCX)
For projects involving planned emergency research. Consent prior to these interventions is waived because of the condition of the subject and urgency under which procedures need to take place. Template is to be used for obtaining consent for continued participation.